Bone Biologics Corporation
BBLG · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$667 | -$741 | -$1,017 | -$1,522 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $73 | $51 | $101 |
| Change in WC | $60 | $210 | $42 | $80 |
| Other Non-Cash | $15 | -$1 | -$1 | -$13 |
| Operating Cash Flow | -$591 | -$459 | -$926 | -$1,353 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $4,353 | $348 | $1,112 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $4,353 | $348 | $1,112 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$591 | $3,894 | -$579 | -$241 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,640 | $2,747 | $3,325 | $3,566 |
| End Cash | $6,049 | $6,640 | $2,747 | $3,325 |
| Free Cash Flow | -$591 | -$459 | -$926 | -$1,353 |